Results 271 to 280 of about 3,948,840 (323)
THE OPERATIVE TREATMENT OF TUBERCULOSIS OF THE LUNGS WITH TOTAL THORACO-PLASTIC PLEUROPNEUMOLYSIS
P. L. Friedrich
openalex +2 more sources
A Python package for fast GPU‐based proton pencil beam dose calculation
Abstract Purpose Open‐source GPU‐based Monte Carlo (MC) proton dose calculation algorithms provide high speed and unparalleled accuracy but can be complex to integrate with new applications and remain slower than GPU‐based pencil beam (PB) methods, which sacrifice some physical accuracy for sub‐second plan calculation.
Mahasweta Bhattacharya+4 more
wiley +1 more source
Decoding mechanisms and protein markers in lung-brain axis. [PDF]
Huang S+11 more
europepmc +1 more source
Lung volumes and forced ventilatory flows
P. Quanjer+5 more
semanticscholar +1 more source
Risk analysis of the Unity 1.5T MR‐Linac adapt‐to‐shape workflow
Abstract Background and Purpose The adapt‐to‐shape (ATS) workflow on the Unity MR‐Linac (Elekta AB, Stockholm, Sweden) allows for full replanning including recontouring and reoptimization5. Additional complexity to this workflow is added when the adaptation involves the use of MIM Maestro (MIM Software, Cleveland, OH) software in conjunction with ...
Jiayi Liang+13 more
wiley +1 more source
Piperlongumine Inhibits Lung Cancer Growth by Inducing Endoplasmic Reticulum Stress Leading to Suppression of M2 Macrophage Polarization. [PDF]
Zhou Y+5 more
europepmc +1 more source
Evaluation of internal target volume of abdominal tumors using cine‐MRI
Abstract Introduction The detailed anatomy visualization with magnetic resonance (MR)‐guided radiotherapy is particularly attractive for abdominal treatments, but patient respiratory motion can compromise image quality. The “navigator technique” produces high‐quality 3D images, triggered by diaphragm displacement, in exhale phase only.
Jessica Lye+8 more
wiley +1 more source
*Mechanisms of circular RNA in drug resistance of lung cancer: therapeutic targets, biomarkers, and future research directions. [PDF]
Tao X, Ke X, Xu G.
europepmc +1 more source